首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >FUNCTIONAL COMPLEMENTATION OF XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP E BY REPLICATION PROTEIN A IN AN IN VITRO SYSTEM
【24h】

FUNCTIONAL COMPLEMENTATION OF XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP E BY REPLICATION PROTEIN A IN AN IN VITRO SYSTEM

机译:体外系统中复制蛋白A对黑皮病补充群E的功能性补充

获取原文
获取原文并翻译 | 示例
       

摘要

Xeroderma pigmentosum (XP) is caused by a defect in nucleotide excision repair. Patients in the complementation group E (XP-E) have the mildest form of the disease and the highest level of residual repair activity. About 20% of the cell strains derived from XP-E patients lack a damaged DNA-binding protein (DDB) activity that binds to ultraviolet-induced (6-4) photoproducts with high affinity. We report here that cell-free extracts prepared from XP-E cell strains that either lacked or contained DDB activity were severely defective in excising DNA damage including (6-4) photoproducts. However, this excision activity defect was not restored by addition of purified DDB that. In fact, inhibited removal of (6-4) photoproducts by the human excision nuclease reconstituted from purified proteins. Extensive purification of correcting activity from HeLa cells revealed that the correcting activity is inseparable from the human replication/repair protein A [RPA (also known as human single stranded DNA binding protein, HSSB)]. Indeed, supplementing XP-E extracts with recombinant human RPA purified from Escherichia coli restored excision activity. However, no mutation was found in the genes encoding the three subunits of RPA in an XP-E (DDB-) cell line. It is concluded that RPA functionally complements XP-E extracts in vitro, but it is not genetically altered in XP-E patients. [References: 40]
机译:色素干皮症(XP)是由核苷酸切除修复中的缺陷引起的。补充组E(XP-E)中的患者患有该病的最轻形式和最高水平的残留修复活性。来自XP-E患者的大约20%的细胞株缺乏受损的DNA结合蛋白(DDB)活性,该活性以高亲和力与紫外线诱导的(6-4)光产物结合。我们在这里报告说,从缺乏或包含DDB活性的XP-E细胞株制备的无细胞提取物在切除DNA损伤(包括(6-4)光产物)方面存在严重缺陷。但是,这种切除活动缺陷不能通过添加纯化的DDB得以恢复。实际上,由从纯化蛋白重构的人类切除核酸酶抑制了(6-4)光产物的去除。从HeLa细胞中广泛纯化校正活性表明,校正活性与人复制/修复蛋白A [RPA(也称为人单链DNA结合蛋白,HSSB)]密不可分。实际上,用从大肠杆菌纯化的重组人RPA补充XP-E提取物可恢复切除活性。但是,在XP-E(DDB-)细胞系中编码RPA的三个亚基的基因中未发现突变。结论是,RPA在体外可以补充XP-E提取物的功能,但在XP-E患者中并未发生遗传改变。 [参考:40]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号